Eric Schlorff - Jul 1, 2025 Form 4 Insider Report for SeaStar Medical Holding Corp (ICU)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Schlorff
Stock symbol
ICU
Transactions as of
Jul 1, 2025
Transactions value $
$0
Form type
4
Date filed
7/3/2025, 04:33 PM
Previous filing
Nov 19, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schlorff Eric Chief Executive Officer, Director C/O SEASTAR MEDICAL HOLDING CORPORATION, 3513 BRIGHTON BLVD., SUITE 410, DENVER /s/ Eric Schlorff 2025-07-03 0001949738

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICU Common Stock, par value $0.0001 per share Options Exercise $0 +21.7K +28.19% $0.00 98.5K Jul 1, 2025 Direct F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICU Restricted Stock Unit Options Exercise $0 -21.7K -100% $0.00 0 Jul 1, 2025 Common Stock, par value $0.0001 per share 21.7K Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed to report the vesting of certain restricted stock unit ("RSU") awards and the moving of unvested RSU awards previously reported in Table II to Table I.
F2 Reflects RSUs that upon vesting converted into shares of ICU common stock.
F3 The total includes 43,333 shares underlying RSUs that were previously reported in Table II.
F4 On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split.
F5 Each restricted stock unit represents a contingent right to receive one share of ICU common stock.
F6 As previously reported, on November 15, 2024, the reporting person was granted 65,000 RSUs, vesting in three approximately equal annual installments on the first, second and third anniversaries of July 1, 2024.
F7 The total does not include 43,333 shares underlying RSUs that are now reported in Table I.